You Searched For: Lovibond+Tintometer

Description: Titration method with Dr Schilling pattern burettes and brown PE bottle.

Catalog Number: 614-0194

UOM: 1 * 1 items

Supplier: GERBER FUNKE

Sale

Description: Anti-HLA-DR Mouse Monoclonal Antibody [clone: L243] (FITC (Fluorescein Isothiocyanate))

Catalog Number: ANTIA86733-100

UOM: 1 * 100 T

Supplier: ANTIBODIES.COM

New Product Sale

Description: White glazed porcelain.

Catalog Number: 519-2394

UOM: 1 * 1 items

Supplier: MORGAN ADVANCED MATERIALS HALD

Sale

Description: Anti-HLA-DRA Rabbit Polyclonal Antibody

Catalog Number: USBI127926

UOM: 1 * 100 µl

Supplier: US Biological

Sale

Description: MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Catalog Number: BNC681090-100

UOM: 1 * 100 µl

Supplier: Biotium

Sale

Description: MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Catalog Number: BNC401090-500

UOM: 1 * 500 µl

Supplier: Biotium

Sale

Description: Anti-SET Goat Polyclonal Antibody

Catalog Number: USBI150962

UOM: 1 * 100 µG

Supplier: US Biological

Sale

Description: The LN3 monoclonal antibody specifically reacts with the human leukocyte antigen-DR (HLA-DR), a MHC class II heterodimeric surface glycoprotein. HLA-DR is expressed on the antigen presenting surfaces of monocytes, macrophages, dendritic cells, activated T cells, and B cells. It is integral to peptide presentation to CD4+ T cells.

Catalog Number: PRSI77-010

UOM: 1 * 100 Tests

Supplier: ProSci Inc.

New Product Sale

Description: Mouse monoclonal antibody raised against HLA-DR.

Catalog Number: ABNOMAB4478

UOM: 1 * 100 µl

Supplier: Abnova

Sale

Description: Mouse monoclonal antibody raised against native HLA-DR/HLA-DP.

Catalog Number: ABNOMAB0917

UOM: 1 * 100 µG

Supplier: Abnova

Sale

Description: Mouse monoclonal antibody raised against human HLA-DP/HLA-DQ/HLA-DR.

Catalog Number: ABNOMAB14681

UOM: 1 * 100 µG

Supplier: Abnova

Sale

Description: This mAb reacts with the HLA-DRB1 antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. It binds a conformational epitope on HLA-DR, which depends on the correct folding of the alpha/beta heterodimer. This mAb has been reported to block mixed lymphocyte reactions. The L243 antibody recognises a different epitope than the LN3 monoclonal antibody, and these antibodies do not cross-block binding to each other's respective epitopes. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kD alpha (heavy) chain and a 28kD beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

Catalog Number: PRSI33-394

UOM: 1 * 100 µG

Supplier: ProSci Inc.

New Product Sale

Description: Mouse monoclonal antibody raised against native HLA-DR.

Catalog Number: ABNOMAB0902

UOM: 1 * 100 µG

Supplier: Abnova

Sale

Description: Mouse monoclonal antibody raised against human HLA-DP/HLA-DQ/HLA-DR.

Catalog Number: ABNOMAB14682

UOM: 1 * 100 µG

Supplier: Abnova

Sale

Description: Mouse monoclonal antibody raised against HLA-DR/HLA-DP.

Catalog Number: ABNOMAB4485

UOM: 1 * 100 Tests

Supplier: Abnova

Sale

Description: MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Catalog Number: BNCB1090-100

UOM: 1 * 100 µl

Supplier: Biotium

Sale